IFITM1 increases osteogenesis through Runx2 in human alveolar-derived bone marrow stromal cells

Bone

Volumn 51, Issue 3, 2012, Pages 506-514

  Kim, Beom Su ^a   Kim, Hyung Jin ^a   Kim, Jin Seong ^a   You, Yong Ouk ^a   Zadeh, Homa ^b   Shin, Hong In ^c   Lee, Seung Jin ^d   Park, Yoon Jeong ^e   Takata, Takashi ^f   Pi, Sung Hee ^a   Lee, Jun ^a   You, Hyung Keun ^a  

^a Wonkwang University   (South Korea)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Kyungpook National University   (South Korea)

^d Ewha Womans University   (South Korea)

^e Seoul National University   (South Korea)

^f HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Alveolar bone marrow; IFITM1; Mesenchymal stromal cells; Osteoblast differentiation; Runx2

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM ION; COLLAGEN TYPE 1; IFITM1 PROTEIN; MESSENGER RNA; OSTEOCALCIN; OSTERIX; REGULATOR PROTEIN; SHORT HAIRPIN RNA; SIALOPROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ALVEOLAR DERIVED BONE MARROW STROMAL CELL; ARTICLE; BONE CELL; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IFITM1 GENE; OSTEOBLAST; PROTEIN EXPRESSION; RUNX2 GENE; STROMA CELL;

ALKALINE PHOSPHATASE; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; BIOLOGICAL MARKERS; BONE AND BONES; CALCIUM; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; OSTEOGENESIS; RNA, SMALL INTERFERING;

EID: 84864772486     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.05.012     Document Type: Article

References (30)

1. Marie P.J. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 2003, 316:23-32.
2. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., Frolova G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6:230-247.
3. Matsubara T., Suardita K., Ishii M., Sugiyama M., Igarashi A., Oda R., et al. Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. J Bone Miner Res 2005, 20:399-409.
4. Cicconetti A., Sacchetti B., Bartoli A., Michienzi S., Corsi A., Funari A., et al. Human maxillary tuberosity and jaw periosteum as sources of osteoprogenitor cells for tissue engineering. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 104:611-612.
5. Akintoye S.O., Lam T., Shi S., Brahim J., Collins M.T., Robey P.G. Skeletal site-specific characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals. Bone 2006, 38:758-768.
6. Pola E., Gao W., Zhou Y., Pola R., Lattanzi W., Sfeir C., et al. Efficient bone formation by gene transfer of human LIM mineralization protein-3. Gene Ther 2004, 11:683-693.
7. Bianco P., Riminucci M., Bonucci E., Termine J.D., Robey P.G. Bone sialoprotein (BSP) secretion and osteoblast differentiation: relationship to bromodeoxyuridine incorporation, alkaline phosphatase, and matrix deposition. J Histochem Cytochem 1993, 41:183-191.
8. Zhang J., Jiang W., Dong Z., Zhao S., Wei F. Simultaneous determination of triazine herbicide residues in maize by gas chromatography. Se Pu 2006, 24:648-651.
9. Friedman R.L., Manly S.P., McMahon M., Kerr I.M., Stark G.R. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 1984, 38:745-755.
10. Deblandre G.A., Marinx O.P., Evans S.S., Majjaj S., Leo O., Caput D., et al. Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J Biol Chem 1995, 270:23860-23866.
11. Andreu P., Colnot S., Godard C., Laurent-Puig P., Lamarque D., Kahn A., et al. Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res 2006, 66:1949-1955.
12. Yang Y., Lee J.H., Kim K.Y., Song H.K., Kim J.K., Yoon S.R., et al. The interferon-inducible 9-27 gene modulates the susceptibility to natural killer cells and the invasiveness of gastric cancer cells. Cancer Lett 2005, 221:191-200.
13. Kim B.S., Kim Y.C., Zadeh H., Park Y.J., Pi S.H., Shin H.S., et al. Effects of the dichloromethane fraction of dipsaci radix on the osteoblastic differentiation of human alveolar bone marrow-derived mesenchymal stem cells. Biosci Biotechnol Biochem 2011, 75:13-19.
14. Kim Y.J., Kwak C.I., Gu Y.Y., Hwang I.T., Chun J.Y. Annealing control primer system for identification of differentially expressed genes on agarose gels. Biotechniques 2004, 36:424-428.
15. Liu H.C., Lee I.C., Wang J.H., Yang S.H., Young T.H. Preparation of PLLA membranes with different morphologies for culture of MG-63 Cells. Biomaterials 2004, 25:4047-4056.
16. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
17. Kotobuki N., Hirose M., Takakura Y., Ohgushi H. Cultured autologous human cells for hard tissue regeneration: preparation and characterization of mesenchymal stem cells from bone marrow. Artif Organs 2004, 28:33-39.
18. Duque G., Huang D.C., Macoritto M., Rivas D., Yang X.F., Ste-Marie L.G., et al. Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells 2009, 27:550-558.
19. Kulterer B., Friedl G., Jandrositz A., Sanchez-Cabo F., Prokesch A., Paar C., et al. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 2007, 8:70.
20. Bellows C.G., Aubin J.E., Heersche J.N. Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate. Bone Miner 1991, 14:27-40.
21. Kita K., Sugaya S., Zhai L., Wu Y.P., Wano C., Chigira S., et al. Involvement of LEU13 in interferon-induced refractoriness of human RSa cells to cell killing by X rays. Radiat Res 2003, 160:302-308.
22. Tanaka S.S., Yamaguchi Y.L., Tsoi B., Lickert H., Tam P.P. IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. Dev Cell 2005, 9:745-756.
23. Yu F., Ng S.S., Chow B.K., Sze J., Lu G., Poon W.S., et al. Knockdown of interferon-induced transmembrane protein 1 (IFITM1) inhibits proliferation, migration, and invasion of glioma cells. J Neurooncol 2011, 103:187-195.
24. Pan Z., Chen S., Pan X., Wang Z., Han H., Zheng W., et al. Differential gene expression identified in Uigur women cervical squamous cell carcinoma by suppression subtractive hybridization. Neoplasma 2010, 57:123-128.
25. Chattopadhyay I., Phukan R., Singh A., Vasudevan M., Purkayastha J., Hewitt S., et al. Molecular profiling to identify molecular mechanism in esophageal cancer with familial clustering. Oncol Rep 2009, 21:1135-1146.
26. Gyorffy B., Dietel M., Fekete T., Lage H. A snapshot of microarray-generated gene expression signatures associated with ovarian carcinoma. Int J Gynecol Cancer 2008, 18:1215-1233.
27. Hatano H., Kudo Y., Ogawa I., Tsunematsu T., Kikuchi A., Abiko Y., et al. IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression. Clin Cancer Res 2008, 14:6097-6105.
28. Brass A.L., Huang I.C., Benita Y., John S.P., Krishnan M.N., Feeley E.M., et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139:1243-1254.
29. Wylie C. IFITM1-mediated cell repulsion controls the initial steps of germ cell migration in the mouse. Dev Cell 2005, 9:723-724.
30. Yang G., Xu Y., Chen X., Hu G. IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene 2007, 26:594-603.